Here are four things to know:
1. The voluntary Field Safety Corrective Action relates to the system’s femoral and tibial insert components.
2. Post-market surveillance data demonstrated patients implanted with the first generation system, “may have a higher risk of requiring a revision earlier than they or their surgeon had expected.”
3. The system’s femoral component was phased out globally in 2013-14.
4. This field action does not affect the Journey II BCS System.
More articles on devices:
5 things to know about Aesculap Implant Systems
5 things to expect from Stryker’s Q2 results
Sen. Todd Young calls on President Trump, Congress to end medical device tax — 6 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
